ANI Pharma, Sofgen Announce FDA Approval Of Nimodipine 30mg Capsules

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) said its ANDA collaboration partner Sofgen has received approval from the U.S. Food and Drug Administration of the Abbreviated New Drug Application for Nimodipine 30mg Capsules.

Trailing twelve-month sales for the product are $25 million, according to IMS Health, with two current competitors. ANI and Sofgen expect to begin shipping to customers this year.

Arthur Przybyl, President and CEO of ANI, said, "This represents ANI's first ANDA approval with our partner Sofgen. We are excited to have achieved this milestone and look forward to a successful launch."